Correlates of non-adherence to antiretroviral therapy in a cohort of HIV-positive drug users receiving antiretroviral therapy in Hanoi, Vietnam

The HIV epidemic in Vietnam is concentrated, with high prevalence estimates among injection drug users and commercial sex workers. Socio-demographics, substance use and clinical correlates of antiretroviral therapy non-adherence were studied in 100 HIV-1 infected drug users receiving antiretroviral therapy for at least 6 months in Hanoi, Vietnam. All study participants were men with a mean age of 29.9 ± 4.9 years. The median duration on antiretroviral therapy was 16.2 ± 12.7 months; 83% reported ‘very good’ or ‘perfect’ adherence in the past 30 days on a subjective one-item Likert scale at time of study enrollment; 48% of participants reported drug use within the previous 6 months, with 22% reporting current drug use. Injection drug use with or without non-injection drug use in the past 6 months (95% C.I. 2.19, 1.30–3.69) and years on antiretroviral therapy (95% C.I. 1.43, 1.14–1.78) were correlated with suboptimal adherence. These findings support Vietnam's ongoing scale-up of harm reduction programmes for injection drug users and their integration with antiretroviral therapy delivery. Moreover, results highlight the need to identify and implement new ways to support high levels of antiretroviral therapy adherence as duration on antiretroviral therapy increases.

[1]  Veronika Timpe Chapter V: Results , 2014 .

[2]  R. Westergaard,et al.  Longitudinal changes in engagement in care and viral suppression for HIV-infected injection drug users , 2013, AIDS.

[3]  M. Dunne,et al.  Factors associated with suboptimal adherence to antiretroviral therapy in Viet Nam: a cross-sectional study using audio computer-assisted self-interview (ACASI) , 2013, BMC Infectious Diseases.

[4]  B. Tran,et al.  Determinants of antiretroviral treatment adherence among HIV/AIDS patients: a multisite study , 2013, Global health action.

[5]  N. Terrin,et al.  Medication Possession Ratio Associated with Short-Term Virologic Response in Individuals Initiating Antiretroviral Therapy in Namibia , 2013, PloS one.

[6]  B. Tran,et al.  Multilevel Predictors of Concurrent Opioid Use during Methadone Maintenance Treatment among Drug Users with HIV/AIDS , 2012, PloS one.

[7]  K. Mulvey,et al.  Methadone Maintenance Therapy in Vietnam: An Overview and Scaling-Up Plan , 2012, Advances in preventive medicine.

[8]  Bach Xuan Tran,et al.  Mobile Phone-Based Antiretroviral Adherence Support in Vietnam: Feasibility, Patient’s Preference, and Willingness-to-Pay , 2012, AIDS and Behavior.

[9]  P. Simkhada,et al.  Factors Influencing Adherence to Antiretroviral Treatment in Nepal: A Mixed-Methods Study , 2012, PloS one.

[10]  I. Wilson,et al.  Evaluation of the Single-Item Self-Rating Adherence Scale for Use in Routine Clinical Care of People Living with HIV , 2012, AIDS and Behavior.

[11]  B. Tran,et al.  Changes in drug use are associated with health-related quality of life improvements among methadone maintenance patients with HIV/AIDS , 2012, Quality of Life Research.

[12]  G. Mbugua,et al.  Factors associated with non-adherence to highly active antiretroviral therapy in Nairobi, Kenya , 2011, AIDS research and therapy.

[13]  A. Rachlis,et al.  Factors associated with virological suppression among HIV‐positive individuals on highly active antiretroviral therapy in a multi‐site Canadian cohort , 2011, HIV medicine.

[14]  S. Lewin,et al.  Pharmacy adherence measures to assess adherence to antiretroviral therapy: review of the literature and implications for treatment monitoring. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  I. Wilson,et al.  Comparison of Antiretroviral Adherence Questions , 2012, AIDS and Behavior.

[16]  D. Maqutu,et al.  Determinants of Optimal Adherence Over Time to Antiretroviral Therapy Amongst HIV Positive Adults in South Africa: A Longitudinal Study , 2011, AIDS and Behavior.

[17]  A. Sasco,et al.  Alcohol use and non-adherence to antiretroviral therapy in HIV-infected patients in West Africa. , 2010, Addiction.

[18]  S. Strathdee,et al.  Epidemiology of HIV Among Injecting and Non-injecting Drug Users: Current Trends and Implications for Interventions , 2010, Current HIV/AIDS reports.

[19]  A. Tang,et al.  Correlates of HIV-1 viral suppression in a cohort of HIV-positive drug users receiving antiretroviral therapy in Hanoi, Vietnam , 2009, International journal of STD & AIDS.

[20]  A. Kamarulzaman Global Epidemiology of Injecting Drug Use and HIV Among People Who Inject Drugs: A Systematic Review , 2008 .

[21]  V. Nguyen,et al.  Drug abuse in Vietnam: a critical review of the literature and implications for future research. , 2008, Addiction.

[22]  O. Laeyendecker,et al.  Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda , 2007, AIDS.

[23]  D. Kroetz,et al.  Adherence-resistance relationships to combination HIV antiretroviral therapy , 2007, Current HIV/AIDS reports.

[24]  I. Wilson,et al.  Optimal Recall Period and Response Task for Self-Reported HIV Medication Adherence , 2007, AIDS and Behavior.

[25]  Richard D Moore,et al.  Hazardous Alcohol Use: A Risk Factor for Non-Adherence and Lack of Suppression in HIV Infection , 2006, Journal of acquired immune deficiency syndromes.

[26]  J. Erlen,et al.  A qualitative study of persons who are 100% adherent to antiretroviral therapy , 2006, AIDS care.

[27]  R. Grant,et al.  Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. , 2002 .

[28]  D. Lipton,et al.  Changes in cocaine use after entry to methadone treatment. , 1991, Journal of addictive diseases.

[29]  O. Miettinen,et al.  Theoretical Epidemiology: Principles of Occurrence Research in Medicine. , 1987 .